This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
midgardfinance.com
midgardfinance.com
did:plc:6elkozr74dmgtebnjmwcre7e
TRIUMPH-1: retatrutide 12 mg, −28.3% at 80 weeks.
Efficacy estimand. Treatment-regimen: −25.0%. Tirzepatide (SURMOUNT-1): −20.9% at 72 weeks.
No HbA1c screen cap at baseline.
🇺🇸 $LLY
https://www.midgardfinance.com/blog/2026/05/21/glp1-obesity-scorecard-2026/
#GLP1 #Retatrutide
[contains quote post or other embedded content]
2026-05-21T21:20:03.065Z